Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EPAM Systems, Inc. | E3M | Nov 25, 2024 | 236.80 | +0.85 |
EPE Special Opportunities Limited | EP0 | Nov 25, 2024 | 1.78 | -1.66 |
EPENDION AB SK 0,3333 | TW4 | Nov 25, 2024 | 7.80 | -2.86 |
Epigenomics AG | ECX | Nov 25, 2024 | 1.30 | +8.33 |
Epiroc A | 3AD1 | Nov 25, 2024 | 16.99 | +1.10 |
EPIROC AB UNSP.ADR/1 | 3ADA | Nov 25, 2024 | 16.60 | +1.22 |
Epiroc B | 3AD2 | Nov 25, 2024 | 15.39 | +1.25 |
Episurf Medical B | 16E | Nov 25, 2024 | 0.00 | -16.67 |
ePlay Digital Inc | 2NY2 | Nov 25, 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | Nov 25, 2024 | 78.50 | +3.29 |
EPR Properties | E2H | Nov 25, 2024 | 43.31 | +1.22 |
EPRCOMUNICAZIONE S.P.A. | J3P | Nov 25, 2024 | 1.05 | 0.00 |
EPTI AB AK | G7H0 | Nov 25, 2024 | 1.71 | 0.00 |
Epwin Group Plc | 2E3 | Nov 25, 2024 | 1.23 | +0.82 |
EQB INC. | V22 | Nov 25, 2024 | 75.00 | +0.67 |
EQL Pharma | 7JK | Nov 25, 2024 | 5.84 | +1.74 |
EQT | 6EQ | Nov 25, 2024 | 26.98 | +2.39 |
EQT Corporation | EQ6 | Nov 25, 2024 | 44.00 | -2.75 |
Eqtec | KEU | Nov 25, 2024 | 0.01 | +6.25 |
Equals Group Plc | 2FX | Nov 25, 2024 | 1.39 | 0.00 |
Equatorial Resources Limited | PBU | Nov 25, 2024 | 0.06 | +2.68 |
Equifax, Inc. | EFX | Nov 25, 2024 | 242.00 | +0.83 |
Equillium, Inc. | 0FY | Nov 25, 2024 | 0.65 | -1.97 |
Equinix, Inc. | EQN2 | Nov 25, 2024 | 891.20 | -0.87 |
Equinor | DNQ | Nov 25, 2024 | 23.20 | -1.70 |
Equinor ASA | DNQA | Nov 25, 2024 | 23.40 | -0.43 |
Equinox Gold Corp | 1LRC | Nov 25, 2024 | 5.27 | -3.97 |
EQUIPMAKE HLDGS LS -,0001 | U8O | Nov 25, 2024 | 0.03 | 0.00 |
Equitable Holdings Inc | AXJ | Nov 25, 2024 | 45.00 | +2.27 |
Equity Bancshares, Inc. - Class A | 44X | Nov 25, 2024 | 46.20 | +5.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.